시장보고서
상품코드
2035813

친화성 리간드 시장 보고서(2026년)

Affinity Ligands Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,228,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 9,003,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 11,778,000
※ 부가세 별도
한글목차
영문목차

친화성 리간드 시장 규모는 최근 몇 년간 크게 성장했습니다.시장 규모는 2025년 18억 3,000만 달러에서 2026년에는 19억 7,000만 달러에 달하고, CAGR 7.6%로 성장할 전망입니다. 지난 몇 년간 성장 요인으로는 표적화 정제 기술에 대한 수요 증가, 제약 및 생명공학 연구 확대, 단백질 기반 리간드 채택, 진단 분야에서의 항체 사용 증가, 학술 및 연구 기관 확대 등을 꼽을 수 있습니다.

친화성 리간드 시장 규모는 향후 몇 년간 강력한 성장이 전망되고 있으며, CAGR 7.8%로 확대되어 2030년에는 26억 6,000만 달러에 이를 것으로 예측됩니다. 예측 기간 동안의 성장 요인으로는 압타머 및 합성 리간드의 채택 확대, 고처리량 신약개발에 대한 수요 증가, 진단 분야에서의 바이오센서 통합 확대, 환경 및 식품 검사 응용 분야 확대, 맞춤형 의료 및 치료법에 대한 관심 증가 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 합성 리간드 및 펩타이드 리간드의 채택 확대, 친수성 크로마토그래피 응용 분야에 대한 수요 증가, 신약 개발 및 진단 분야로의 통합 발전, 고특이성 바이오센서 플랫폼의 확대, 단백질 및 효소 정제 기술에 대한 관심 증가 등이 있습니다.

바이오 의약품 생산에 대한 수요 증가는 향후 몇 년 동안 친연성 리간드 시장의 확대를 가속화할 것으로 예측됩니다. 바이오의약품 생산은 생물 유래 시스템 및 공정을 이용하여 단클론 항체, 백신, 재조합 단백질 등 복잡한 생물학적 치료 제품을 대규모로 산업적으로 제조하는 것을 말합니다. 만성질환 및 감염성 질환의 유병률이 증가함에 따라 이러한 건강 상태를 효과적으로 치료하고 관리하기 위한 첨단 치료법, 백신, 생물학적 제제에 대한 요구가 증가하고 있으며, 바이오의약품 생산에 대한 수요가 증가하고 있습니다. 친연성 리간드는 복잡한 혼합물에서 표적 생체 분자를 분리하는 고특이성 결합 부위를 제공함으로써 바이오 의약품 제조를 개선하고 신속하고 효율적인 정제와 일관된 제품 품질을 실현합니다. 예를 들어, 2023년 6월 유럽제약산업협회연맹(EFPIA)에 따르면, 유럽 제약산업을 대표하는 벨기에에 본부를 둔 업계 단체인 EFPIA의 보고서에 따르면, 2023년 유럽의 총 제약 생산액은 3,900억 유로(4,228억 300만 달러)에 달할 것으로 예상되며, 2022년 3,633억 유로(3,938억 5,700만 달러)(3,938억 5,700만 달러)에서 증가했습니다. 따라서 바이오의약품 생산에 대한 수요 증가는 친연성 리간드 시장 확대에 기여하고 있습니다.

친연성 리간드 시장에서 활동하는 주요 기업들은 처리 속도 향상, 결합 능력 개선, 다운스트림 바이오프로세스의 워크플로우 효율화를 위해 멤브레인 기반 단백질 A 크로마토그래피 플랫폼과 같은 첨단 정제 솔루션 개발에 주력하고 있습니다. 멤브레인 기반 단백질 A 크로마토그래피 플랫폼은 멤브레인 구조 내에 단백질 A 친화성 리간드를 내장한 첨단 정제 기술로, 복잡한 바이오프로세스액에서 단일클론항체를 특이적으로 결합 및 분리하여 하류 바이오 제조 공정의 처리량 증대 및 효율을 향상시킵니다. 및 효율성 향상을 실현합니다. 예를 들어, 2024년 10월 독일에 본사를 둔 바이오 제약 솔루션 제공업체인 Sartorius AG는 단일클론항체를 신속하고 효율적으로 포획하기 위한 실험실 규모의 멤브레인 크로마토그래피 장비인 'Sartobind Rapid A Lab'을 출시하였습니다. 이 솔루션은 막 흡착제에 내장된 단백질 A 친화성 리간드를 활용하여 높은 결합 용량, 짧은 사이클 타임 및 실험실에서 제조 현장까지 확장성을 실현함으로써 공정의 집적화를 지원하고 바이오 의약품 개발을 가속화합니다.

자주 묻는 질문

  • 친화성 리간드 시장 규모는 어떻게 변화하고 있나요?
  • 친화성 리간드 시장의 성장 요인은 무엇인가요?
  • 바이오 의약품 생산에 대한 수요 증가는 친화성 리간드 시장에 어떤 영향을 미치나요?
  • 친화성 리간드 시장에서 주요 기업들은 어떤 기술 개발에 주력하고 있나요?
  • Sartorius AG는 어떤 제품을 출시했나요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남아메리카 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 시장에서 주목 받는 스타트업

제40장 주요 인수합병(M&A)

제41장 시장 잠재력이 높은 국가, 부문, 전략

제42장 부록

LSH 26.06.04

Affinity ligands are molecules that selectively bind to a target biomolecule through non-covalent interactions such as hydrogen bonding, ionic forces, or hydrophobic effects. They are commonly used to capture, isolate, or detect specific proteins, enzymes, or other biological molecules. Their high specificity and reversible binding make them essential tools in purification and analytical techniques.

The prominent product types of affinity ligands include protein-based ligands, synthetic ligands, peptide ligands, aptamers, and other types. Protein-based ligands are molecules engineered to selectively bind target biomolecules for purification, detection, or therapeutic purposes. Target molecules include antibodies, proteins, enzymes, nucleic acids, and small molecules. Applications include affinity chromatography, biosensors, diagnostics, therapeutics, research and development, and drug discovery, serving industries such as pharmaceutical and biotechnology companies, academic and research institutes, diagnostic laboratories, contract research organizations, food and beverage sectors, and environmental testing.

Tariffs on imported reagents, ligand materials, and analytical instruments are impacting the affinity ligands market by increasing costs for manufacturing and procurement, particularly affecting synthetic ligands, peptide ligands, and aptamer segments. Regions such as North America, Europe, and Asia-Pacific, which rely on imported biomolecules and lab equipment, are most affected. While tariffs raise operational expenses, they also incentivize local production, encourage development of cost-efficient ligand synthesis, and stimulate regional innovation, ultimately supporting a more resilient supply chain.

The affinity ligands market research report is one of a series of new reports from The Business Research Company that provides affinity ligands market statistics, including affinity ligands industry global market size, regional shares, competitors with a affinity ligands market share, detailed affinity ligands market segments, market trends and opportunities, and any further data you may need to thrive in the affinity ligands industry. This affinity ligands market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The affinity ligands market size has grown strongly in recent years. It will grow from $1.83 billion in 2025 to $1.97 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing demand for targeted purification techniques, growth of pharmaceutical and biotech research, adoption of protein-based ligands, rising use of antibodies in diagnostics, expansion of academic and research institutes.

The affinity ligands market size is expected to see strong growth in the next few years. It will grow to $2.66 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to growing adoption of aptamers and synthetic ligands, increasing demand for high-throughput drug discovery, rising integration of biosensors in diagnostics, expansion of environmental and food testing applications, growing focus on personalized medicine and therapeutics. Major trends in the forecast period include increasing adoption of synthetic and peptide ligands, rising demand for affinity chromatography applications, growing integration in drug discovery and diagnostics, expansion of high-specificity biosensor platforms, rising focus on protein and enzyme purification techniques.

The growing demand for biopharmaceutical production is anticipated to accelerate the expansion of the affinity ligands market in the coming years. Biopharmaceutical production refers to the large-scale industrial manufacturing of complex biological therapeutic products, including monoclonal antibodies, vaccines, and recombinant proteins, using biologically derived systems and processes. The demand for biopharmaceutical production is increasing due to the rising prevalence of chronic and infectious diseases, which is elevating the need for advanced therapies, vaccines, and biologic drugs to effectively treat and manage these health conditions. Affinity ligands enhance biopharmaceutical manufacturing by providing highly specific binding sites that isolate target biomolecules from complex mixtures, enabling rapid and efficient purification as well as consistent product quality. For example, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry in Europe, total pharmaceutical production in Europe reached €390,000 million ($422,803 million) in 2023, compared to €363,300 million ($393,857 million) in 2022. Therefore, the growing demand for biopharmaceutical production is contributing to the expansion of the affinity ligands market.

Leading companies operating in the affinity ligands market are focusing on developing advanced purification solutions such as membrane-based protein A chromatography platforms to enhance processing speed, improve binding capacity, and streamline downstream bioprocessing workflows. Membrane-based protein A chromatography platforms are advanced purification technologies that incorporate protein A affinity ligands within membrane structures to specifically bind and isolate monoclonal antibodies from complex bioprocess fluids, enabling faster throughput and enhanced efficiency in downstream biomanufacturing operations. For example, in October 2024, Sartorius AG, a Germany-based biopharmaceutical solutions provider, launched Sartobind Rapid A Lab, a laboratory-scale membrane chromatography device designed for fast and efficient capture of monoclonal antibodies. The solution leverages Protein A affinity ligands integrated into membrane adsorbers to deliver high binding capacity, short cycle times, and scalability from lab to manufacturing, supporting process intensification and accelerating biologics development.

In September 2023, Navigo Proteins GmbH, a Germany-based protein engineering company specializing in affinity ligands, formed a partnership with Nostrum Biodiscovery S.L. to advance the discovery of Affilin ligands using artificial intelligence (AI) and molecular modeling approaches. Through this collaboration, Navigo Proteins GmbH and Nostrum Biodiscovery S.L. aim to optimize the design of ubiquitin-based Affilin ligands with strong affinity and specificity, supporting the advancement of next-generation targeted therapeutics such as radiotheranostics and drug conjugates. Nostrum Biodiscovery S.L. is a Spain-based organization focused on AI-powered molecular modeling and protein engineering for therapeutics and bio-based chemistry.

Major companies operating in the affinity ligands market are Thermo Fisher Scientific Inc., Merck KGaA, Cube Biotech GmbH, Tosoh Corporation, Avantor Inc., Agilent Technologies Inc., Kaneka Corporation, Sartorius AG, PerkinElmer Inc., Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Repligen Corporation, GenScript Biotech Corporation, Purolite Corporation, Promega Corporation, Takara Bio Inc., BioWorks Inc., Biotage AB, BIA Separation d.o.o., KNAUER Wissenschaftliche Gerate GmbH, JNC Corporation, Aptamer Group.

North America was the largest region in the affinity ligands market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the affinity ligands market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the affinity ligands market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The affinity ligands market consists of sales of affinity chromatography columns, magnetic separation beads, resin-packed cartridges, and ligand-coated microplates. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Affinity Ligands Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses affinity ligands market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for affinity ligands ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The affinity ligands market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Protein-Based Ligands; Synthetic Ligands; Peptide Ligands; Aptamers; Other Product Types
  • 2) By Target Molecule: Antibodies; Proteins; Enzymes; Nucleic Acids; Small Molecules
  • 3) By Application: Affinity Chromatography; Biosensors; Diagnostics; Therapeutics; Research And Development; Drug Discovery
  • 4) By End-Use Industry: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Diagnostic Laboratories; Contract Research Organizations; Food And Beverage Industry; Environmental Testing
  • Subsegments:
  • 1) By Protein-Based Ligands: Antibodies; Enzymes; Lectins; Albumins
  • 2) By Synthetic Ligands: Small Molecules; Polymers; Dendrimers; Magnetic Particles
  • 3) By Peptide Ligands: Linear Peptides; Cyclic Peptides; Modified Peptides; Functionalized Peptides
  • 4) By Aptamers: Deoxyribonucleic Acid Aptamers; Ribonucleic Acid Aptamers; Peptide Aptamers; Spiegelmers
  • 5) By Other Product Types: Carbohydrate Ligands; Lipid Ligands; Nucleic Acid Ligands; Hybrid Ligands
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Cube Biotech GmbH; Tosoh Corporation; Avantor Inc.; Agilent Technologies Inc.; Kaneka Corporation; Sartorius AG; PerkinElmer Inc.; Waters Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Repligen Corporation; GenScript Biotech Corporation; Purolite Corporation; Promega Corporation; Takara Bio Inc.; BioWorks Inc.; Biotage AB; BIA Separation d.o.o.; KNAUER Wissenschaftliche Gerate GmbH; JNC Corporation; Aptamer Group.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Affinity Ligands Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Affinity Ligands Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Affinity Ligands Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Affinity Ligands Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption of Synthetic and Peptide Ligands
    • 4.2.2 Rising Demand for Affinity Chromatography Applications
    • 4.2.3 Growing Integration in Drug Discovery and Diagnostics
    • 4.2.4 Expansion of High-Specificity Biosensor Platforms
    • 4.2.5 Rising Focus on Protein and Enzyme Purification Techniques

5. Affinity Ligands Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical And Biotechnology Companies
  • 5.2 Academic And Research Institutes
  • 5.3 Diagnostic Laboratories
  • 5.4 Contract Research Organizations
  • 5.5 Food And Beverage Industry

6. Affinity Ligands Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Affinity Ligands Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Affinity Ligands PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Affinity Ligands Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Affinity Ligands Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Affinity Ligands Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Affinity Ligands Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Affinity Ligands Market Segmentation

  • 9.1. Global Affinity Ligands Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Protein-Based Ligands, Synthetic Ligands, Peptide Ligands, Aptamers, Other Product Types
  • 9.2. Global Affinity Ligands Market, Segmentation By Target Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Antibodies, Proteins, Enzymes, Nucleic Acids, Small Molecules
  • 9.3. Global Affinity Ligands Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Affinity Chromatography, Biosensors, Diagnostics, Therapeutics, Research And Development, Drug Discovery
  • 9.4. Global Affinity Ligands Market, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Diagnostic Laboratories, Contract Research Organizations, Food And Beverage Industry, Environmental Testing
  • 9.5. Global Affinity Ligands Market, Sub-Segmentation Of Protein-Based Ligands, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Antibodies, Enzymes, Lectins, Albumins
  • 9.6. Global Affinity Ligands Market, Sub-Segmentation Of Synthetic Ligands, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Small Molecules, Polymers, Dendrimers, Magnetic Particles
  • 9.7. Global Affinity Ligands Market, Sub-Segmentation Of Peptide Ligands, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Linear Peptides, Cyclic Peptides, Modified Peptides, Functionalized Peptides
  • 9.8. Global Affinity Ligands Market, Sub-Segmentation Of Aptamers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Deoxyribonucleic Acid Aptamers, Ribonucleic Acid Aptamers, Peptide Aptamers, Spiegelmers
  • 9.9. Global Affinity Ligands Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Carbohydrate Ligands, Lipid Ligands, Nucleic Acid Ligands, Hybrid Ligands

10. Affinity Ligands Market Regional And Country Analysis

  • 10.1. Global Affinity Ligands Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Affinity Ligands Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Affinity Ligands Market

  • 11.1. Asia-Pacific Affinity Ligands Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Affinity Ligands Market

  • 12.1. China Affinity Ligands Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Affinity Ligands Market

  • 13.1. India Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Affinity Ligands Market

  • 14.1. Japan Affinity Ligands Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Affinity Ligands Market

  • 15.1. Australia Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Affinity Ligands Market

  • 16.1. Indonesia Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Affinity Ligands Market

  • 17.1. South Korea Affinity Ligands Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Affinity Ligands Market

  • 18.1. Taiwan Affinity Ligands Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Affinity Ligands Market

  • 19.1. South East Asia Affinity Ligands Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Affinity Ligands Market

  • 20.1. Western Europe Affinity Ligands Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Affinity Ligands Market

  • 21.1. UK Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Affinity Ligands Market

  • 22.1. Germany Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Affinity Ligands Market

  • 23.1. France Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Affinity Ligands Market

  • 24.1. Italy Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Affinity Ligands Market

  • 25.1. Spain Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Affinity Ligands Market

  • 26.1. Eastern Europe Affinity Ligands Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Affinity Ligands Market

  • 27.1. Russia Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Affinity Ligands Market

  • 28.1. North America Affinity Ligands Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Affinity Ligands Market

  • 29.1. USA Affinity Ligands Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Affinity Ligands Market

  • 30.1. Canada Affinity Ligands Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Affinity Ligands Market

  • 31.1. South America Affinity Ligands Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Affinity Ligands Market

  • 32.1. Brazil Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Affinity Ligands Market

  • 33.1. Middle East Affinity Ligands Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Affinity Ligands Market

  • 34.1. Africa Affinity Ligands Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Affinity Ligands Market, Segmentation By Product Type, Segmentation By Target Molecule, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Affinity Ligands Market Regulatory and Investment Landscape

36. Affinity Ligands Market Competitive Landscape And Company Profiles

  • 36.1. Affinity Ligands Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Affinity Ligands Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Affinity Ligands Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Cube Biotech GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Tosoh Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Avantor Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Affinity Ligands Market Other Major And Innovative Companies

  • Agilent Technologies Inc., Kaneka Corporation, Sartorius AG, PerkinElmer Inc., Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Repligen Corporation, GenScript Biotech Corporation, Purolite Corporation, Promega Corporation, Takara Bio Inc., BioWorks Inc., Biotage AB, BIA Separation d.o.o.

38. Global Affinity Ligands Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Affinity Ligands Market

41. Affinity Ligands Market High Potential Countries, Segments and Strategies

  • 41.1 Affinity Ligands Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Affinity Ligands Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Affinity Ligands Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기